Skip over navigation
Directory
Directory Search
Jobs
Job Search
Post a Job
Patient
Patient Resources
Drug Development
History
Genealogy
Toons & Teasers
About
Advertising
Home
Quick Links
Directory
Job Search
Toons & Teasers
Advertising
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Industry News
Search Articles:
Teva announces FDA acceptance of resubmitted NDA for SD-809 for chorea associated with HD
Teva announced the FDA has accepted the resubmission of the New Drug Application (for SD-809 (deutetrabenazine) for treatment of chorea associated with Huntington disease (HD). The FDA has assigned a PDUFA goal date of April 3, 2017.
October 20, 2016
More...
Email This Page
to a Friend
Print This
Page